Therefore, the elucidation of these mechanisms is necessary for a better understanding of the effect of GPER in carcinogenesis and tumor progression, making the estrogen signaling a potential therapeutic target in female reproductive cancers. This evidence concerns the gene GPER1 and female reproductive organ cancer.